These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 33684289)

  • 1. Targeted Regulation of Blood-Brain Barrier for Enhanced Therapeutic Efficiency of Hypoxia-Modifier Nanoparticles and Immune Checkpoint Blockade Antibodies for Glioblastoma.
    Meng L; Wang C; Lu Y; Sheng G; Yang L; Wu Z; Xu H; Han C; Lu Y; Han F
    ACS Appl Mater Interfaces; 2021 Mar; 13(10):11657-11671. PubMed ID: 33684289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
    Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
    Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual functional nanoparticles efficiently across the blood-brain barrier to combat glioblastoma
    Jin Z; Piao L; Sun G; Lv C; Jing Y; Jin R
    J Drug Target; 2021 Mar; 29(3):323-335. PubMed ID: 33108906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted opening of the blood-brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma.
    Pol JG; Lizarralde-Guerrero M; Checcoli A; Kroemer G
    Oncoimmunology; 2024; 13(1):2385124. PubMed ID: 39076248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy.
    Yang ZZ; Gao W; Liu YJ; Pang N; Qi XR
    Mol Pharm; 2017 Apr; 14(4):1012-1022. PubMed ID: 28252970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducing a Transient Increase in Blood-Brain Barrier Permeability for Improved Liposomal Drug Therapy of Glioblastoma Multiforme.
    Lundy DJ; Lee KJ; Peng IC; Hsu CH; Lin JH; Chen KH; Tien YW; Hsieh PCH
    ACS Nano; 2019 Jan; 13(1):97-113. PubMed ID: 30532951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: tumor-specific homing directed by nestin.
    Prabhu S; Goda JS; Mutalik S; Mohanty BS; Chaudhari P; Rai S; Udupa N; Rao BSS
    Nanoscale; 2017 Aug; 9(30):10919-10932. PubMed ID: 28731079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier.
    Lim SH; Yee GT; Khang D
    Int J Nanomedicine; 2024; 19():2529-2552. PubMed ID: 38505170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Delivery of Nanoparticle-Conveyed Neutrophils to the Glioblastoma Site for Efficient Therapy.
    Piao C; Lee J; Kim GE; Choe YH; Lee H; Hyun YM
    ACS Appl Mater Interfaces; 2024 Aug; 16(32):41819-41827. PubMed ID: 39057192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier.
    Da Ros M; De Gregorio V; Iorio AL; Giunti L; Guidi M; de Martino M; Genitori L; Sardi I
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models.
    Sandbhor P; Goda J; Mohanty B; Chaudhari P; Dutt S; Banerjee R
    Nanoscale; 2021 Dec; 14(1):108-126. PubMed ID: 34897360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges to Successful Implementation of the Immune Checkpoint Inhibitors for Treatment of Glioblastoma.
    Sanders S; Debinski W
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Macrophage-Membrane-Coated Nanoparticles with Enhanced PD-1 Expression Induce Immunomodulation for a Synergistic and Targeted Antiglioblastoma Activity.
    Yin T; Fan Q; Hu F; Ma X; Yin Y; Wang B; Kuang L; Hu X; Xu B; Wang Y
    Nano Lett; 2022 Aug; 22(16):6606-6614. PubMed ID: 35948420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment.
    Zhang CX; Zhao WY; Liu L; Ju RJ; Mu LM; Zhao Y; Zeng F; Xie HJ; Yan Y; Lu WL
    Oncotarget; 2015 Oct; 6(32):32681-700. PubMed ID: 26418720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma.
    Zhang N; Wei L; Ye M; Kang C; You H
    Front Immunol; 2020; 11():592612. PubMed ID: 33329578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charge-switchable cell-penetrating peptides for rerouting nanoparticles to glioblastoma treatment.
    Mendes M; Nunes S; Cova T; Branco F; Dyrks M; Koksch B; Vale N; Sousa J; Pais A; Vitorino C
    Colloids Surf B Biointerfaces; 2024 Sep; 241():113983. PubMed ID: 38850741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopep-2-Functionalized Lipid Cubosomes for Blood-Brain Barrier Crossing and Glioblastoma Treatment.
    Cai X; Refaat A; Gan PY; Fan B; Yu H; Thang SH; Drummond CJ; Voelcker NH; Tran N; Zhai J
    ACS Appl Mater Interfaces; 2024 Mar; 16(10):12161-12174. PubMed ID: 38416873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored polymer-lipid hybrid nanoparticles for the delivery of drug conjugate: dual strategy for brain targeting.
    Agrawal U; Chashoo G; Sharma PR; Kumar A; Saxena AK; Vyas SP
    Colloids Surf B Biointerfaces; 2015 Feb; 126():414-25. PubMed ID: 25601092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of enhanced antiglioma efficacy of polysorbate 80-modified paclitaxel-loaded PLGA nanoparticles by focused ultrasound.
    Li Y; Wu M; Zhang N; Tang C; Jiang P; Liu X; Yan F; Zheng H
    J Cell Mol Med; 2018 Sep; 22(9):4171-4182. PubMed ID: 29956460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.